The Bapineuzumab phase 3 carrier trials are complete as of April 20th acoording to clinicaltrials.gov! We are so close to hearing about the data from this trial! Come on Intellect get that US patent!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.